Growth Metrics

Valion Bio (TIVC) Share-based Compensation (2021 - 2025)

Valion Bio has reported Share-based Compensation over the past 5 years, most recently at $471000.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation changed N/A year-over-year to $471000.0; the TTM value through Dec 2025 reached $886000.0, up 433.73%, while the annual FY2025 figure was $564000.0, N/A changed from the prior year.
  • Share-based Compensation for Q4 2025 was $471000.0 at Valion Bio, up from $138000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $471000.0 in Q4 2025 and troughed at $8000.0 in Q2 2021.
  • A 5-year average of $99526.3 and a median of $61000.0 in 2022 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 1306.25% in 2022 and later plummeted 74.22% in 2023.
  • Year by year, Share-based Compensation stood at $16000.0 in 2021, then skyrocketed by 1306.25% to $225000.0 in 2022, then plummeted by 74.22% to $58000.0 in 2023, then changed by 0.0% to $58000.0 in 2024, then surged by 712.07% to $471000.0 in 2025.
  • Business Quant data shows Share-based Compensation for TIVC at $471000.0 in Q4 2025, $138000.0 in Q3 2025, and $177000.0 in Q2 2025.